Skip to main navigation Skip to search Skip to main content

Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome [9]

  • H. M. Robinson
  • , Z. J. Broadfield
  • , K. L. Cheung
  • , L. Harewood
  • , R. L. Harris
  • , G. R. Jalali
  • , M. Martineau
  • , A. V. Moorman
  • , K. E. Taylor
  • , S. Richards
  • , C. Mitchell
  • , C. J. Harrison*
  • *Corresponding author for this work
  • University of Southampton
  • Oxford University Hospitals NHS Foundation Trust
  • National Institute for Health Research (NIHR) Oxford Biomedical Research Centre John Radcliffe Hospital United Kingdom (S.T.P.).

Research output: Contribution to journalComment/Letter to the editorAcademic

Original languageEnglish
Pages (from-to)2249-2250
JournalLeukemia
Volume17
Issue number11
DOIs
Publication statusPublished - 2003
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this